Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain.
about
Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development.Shikonin-mediated up-regulation of miR-34a and miR-202 inhibits retinoblastoma proliferationA high-throughput fluorescence polarization assay for discovering inhibitors targeting the DNA-binding domain of signal transducer and activator of transcription 3 (STAT3)
P2860
Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Identification of New Shikonin ...... ts Targeting STAT3 SH2 Domain.
@ast
Identification of New Shikonin ...... ts Targeting STAT3 SH2 Domain.
@en
type
label
Identification of New Shikonin ...... ts Targeting STAT3 SH2 Domain.
@ast
Identification of New Shikonin ...... ts Targeting STAT3 SH2 Domain.
@en
prefLabel
Identification of New Shikonin ...... ts Targeting STAT3 SH2 Domain.
@ast
Identification of New Shikonin ...... ts Targeting STAT3 SH2 Domain.
@en
P2093
P2860
P1433
P1476
Identification of New Shikonin ...... ts Targeting STAT3 SH2 Domain.
@en
P2093
Cheng-Yi Tang
Han-Yue Qiu
Hong-Yan Lin
Jin-Liang Qi
Rong-Wu Yang
Xiao-Ming Wang
Yan-Jun Pang
Yong-Hua Yang
Yue-Lin Luo
P2860
P2888
P356
10.1038/S41598-017-02671-7
P407
P50
P577
2017-06-06T00:00:00Z
P6179
1085782756